Cargando…
Zooming into Gut Dysbiosis in Parkinson’s Disease: New Insights from Functional Mapping
Gut dysbiosis has been involved in the pathogenesis and progression of Parkinson’s disease (PD), but the mechanisms through which gut microbiota (GM) exerts its influences deserve further study. Recently, we proposed a two-hit mouse model of PD in which ceftriaxone (CFX)-induced dysbiosis amplifies...
Autores principales: | Turco, Luigia, Opallo, Nicola, Buommino, Elisabetta, De Caro, Carmen, Pirozzi, Claudio, Mattace Raso, Giuseppina, Lembo, Francesca, Coretti, Lorena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253733/ https://www.ncbi.nlm.nih.gov/pubmed/37298727 http://dx.doi.org/10.3390/ijms24119777 |
Ejemplares similares
-
Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
por: Pirozzi, Claudio, et al.
Publicado: (2023) -
Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate
por: Avagliano, Carmen, et al.
Publicado: (2022) -
Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains
por: Fusco, Alessandra, et al.
Publicado: (2017) -
N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition
por: Lama, Adriano, et al.
Publicado: (2019) -
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders
por: Coretti, Lorena, et al.
Publicado: (2019)